Cointime

Cytonics

company

About

Cytonics is a biotechnology company developing diagnostic assays focusing on musculoskeletal-related pain.

  • 51 - 100

Highlights

Total Funding Amount
$1.60M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.60M
Industries
Biotechnology,Fitness,Health Diagnostics
Founded date
Jan 1, 2006
Number Of Employee
51 - 100
Operating Status
Active

Cytonics Corporation, a biotechnology company, develops diagnostic assays focusing on musculoskeletal related pain. It offers Fibronectin Aggrecan Complex Test (FACT) for molecular discography and FACT Plus multi analyte assay for diagnosing the source of pain in the spine and joints. Additionally, the company provides proteomics research and development services. Cytonics Corporation was founded in 2006 and is based in Jupiter, Florida.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.60M
Cytonics has raised a total of $1.60M in funding over 2 rounds. Their latest funding was raised on Nov 14, 2012 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 14, 2012 Grant $1.60M 1 National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cytonics is funded by 1 investors. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) are the most recent investors.
Investor Name Lead Investor Funding Round
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Yes Grant
Cointime
Insight
Features
RSS
Company